UBE2N and neoplasm: This study not only revealed the association of UBE2N expression with tumor clinicopathological progression but also shed further light on the role and potential of UBE2N from the perspective of tumor immunity and therapeutics, and suggested that UBE2N could serve as a robust biomarker for tumor progression and therapeutic susceptibility.